Spermine alleviates experimental autoimmune encephalomyelitis via regulating T cell activation and differentiation
文献类型:期刊论文
作者 | Zheng, Ruting2,5,6; Kong, Miaomiao4; Wang, Siwei5,6; He, Bingqing2,5,6; Xie, Xin1,2,3,4,5,6![]() |
刊名 | INTERNATIONAL IMMUNOPHARMACOLOGY
![]() |
出版日期 | 2022-06-01 |
卷号 | 107页码:11 |
关键词 | Spermine Polyamines Multiple Sclerosis EAE Th1 Th17 MAPK pathway ERK |
ISSN号 | 1567-5769 |
DOI | 10.1016/j.intimp.2022.108702 |
通讯作者 | Xie, Xin(xxie@simm.ac.cn) |
英文摘要 | Multiple sclerosis (MS) is a chronic neuroinflammatory disease which causes demyelination, axonal damage and even disability. Th1 and Th17 cells, more precisely, the IFN gamma/IL17a double producing CD4(+) T cells, have been known to play critical roles in the pathogenesis of MS and EAE, a mouse model of MS. Polyamines not only regulate the immune system, but also are essential for the normal function of the central nervous system (CNS). In this study, we demonstrate that the supplementation of spermine (SPM), a biogenic polyamine, significantly suppresses EAE progression in both preventative and therapeutic ways. Further study suggests that spermine significantly reduces IFN gamma(+)/IL17a(-), IFN gamma(-)/IL17a(+) and IFN gamma(+)/IL17a(+) cells in periphery, and thus reducing the infiltration of these pathogenic cells into the CNS. In vitro, spermine has been shown to suppress the activation and proliferation of CD4(+) T cells and also significantly impede the polarization of T effector cells in a dose dependent manner, accompanied by the inhibition of ERK phosphorylation. Consistently, a number of MEK/ ERK inhibitors (including PD0325901, FR180204 and selumetinib) have been found to mimic the effects of spermine in inhibiting CD4(+) T cell activation and T effector cell differentiation. Collectively, spermine alleviates EAE progression by inhibiting CD4(+) T cells activation and T effector cell differentiation in a MAPK/ ERK-dependent manner, suggesting this pathway might be a target to develop effective therapies for MS. |
WOS关键词 | TH17 CELLS ; SIGNAL-TRANSDUCTION ; MEMORY ; TCR ; PATHOGENESIS ; INHIBITION ; POLYAMINES ; THERAPY ; PATHWAY |
资助项目 | National Natural Sci-ence Foundation of China[82121005] ; National Natural Sci-ence Foundation of China[81730099] ; Shanghai Science and Technology Commission[TM202101H005] |
WOS研究方向 | Immunology ; Pharmacology & Pharmacy |
语种 | 英语 |
WOS记录号 | WOS:000793198400004 |
出版者 | ELSEVIER |
源URL | [http://119.78.100.183/handle/2S10ELR8/300965] ![]() |
专题 | 新药研究国家重点实验室 |
通讯作者 | Xie, Xin |
作者单位 | 1.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China 2.ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China 3.Univ Chinese Acad Sci, Hangzhou Inst Adv Study, Sch Pharmaceut Sci & Technol, Hangzhou, Peoples R China 4.China Pharmaceut Univ, Acad Inst Pharmaceut Sci, Nanjing 210009, Peoples R China 5.Univ Chinese Acad Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China 6.Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Natl Ctr Drug Screening, Shanghai 201203, Peoples R China |
推荐引用方式 GB/T 7714 | Zheng, Ruting,Kong, Miaomiao,Wang, Siwei,et al. Spermine alleviates experimental autoimmune encephalomyelitis via regulating T cell activation and differentiation[J]. INTERNATIONAL IMMUNOPHARMACOLOGY,2022,107:11. |
APA | Zheng, Ruting,Kong, Miaomiao,Wang, Siwei,He, Bingqing,&Xie, Xin.(2022).Spermine alleviates experimental autoimmune encephalomyelitis via regulating T cell activation and differentiation.INTERNATIONAL IMMUNOPHARMACOLOGY,107,11. |
MLA | Zheng, Ruting,et al."Spermine alleviates experimental autoimmune encephalomyelitis via regulating T cell activation and differentiation".INTERNATIONAL IMMUNOPHARMACOLOGY 107(2022):11. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。